Caffeine for preterm infants: current indications and uncertainties

Caffeine for preterm infants: current indications and uncertainties

Authors

  • S. Nobile Neonatology Unit, Salesi Children’s Hospital, Ancona (Italy)
  • V. P. Carnielli Neonatology Unit, Salesi Children’s Hospital, Ancona (Italy)

Keywords:

caffeine, preterm infant, apnea, bronchopulmonary dysplasia

Abstract

Caffeine is one of the most commonly used therapies in Neonatology, with different indications such as the treatment of apnea and the prevention of extubation failure and bronchopulmonary dysplasia. However, there are still uncertainties regarding effects on central nervous system development, time of discontinuation and dosing of the drug.

Downloads

Published

29-06-2015

Issue

Vol. 86 No. 1S (2015): Meeting on Surfactant 2015 - From the ELGA to Late preterm: which respiratory management? Parma, Italy, June 18rd 2015

Section

ORIGINAL ARTICLES

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Nobile S, Carnielli VP. Caffeine for preterm infants: current indications and uncertainties. Acta Biomed [Internet]. 2015 Jun. 29 [cited 2024 Jul. 27];86(1S):32-5. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/4542